ArticleJournal of Crohn's & colitis2019

Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease.

Ming-Hsi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.